¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Pulmonary valve disorders"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • intralobar pulmonary sequestration
    ¿±³»ÇãÆÄºÐ¸®Áõ, ¿±³»ÆóºÐ¸®Áõ
  • neurogenic pulmonary edema
    ½Å°æ¼ºÆóºÎÁ¾
  • obstructive pulmonary disease
    Æó¼âÆóº´
  • plexogenic pulmonary arteriopathy
    ¾ó±âÇü¼ºÆóµ¿¸Æº´(Áõ)
  • pulmonary
    Æó-, ÇãÆÄ-
  • pulmonary actinomycosis
    Æó¹æ¼±±ÕÁõ, ÇãÆÄ¹ÙÄû»ì±ÕÁõ
  • pulmonary adenomatosis
    Æó»ùÁ¾Áõ, Æó¼±Á¾Áõ
  • pulmonary alveolar microlithiasis
    ÆóÆ÷¹Ì¼¼°á¼®Áõ
  • pulmonary alveolar proteinosis
    ÇãÆÄ²Ê¸®´Ü¹éÁõ, ÆóÆ÷´Ü¹éÁõ
  • pulmonary alveolus
    ÇãÆÄ²Ê¸®, ÆóÆ÷
  • pulmonary arch
    Æóµ¿¸ÆÈ°
  • pulmonary arteriosclerosis
    Æóµ¿¸Æ°æÈ­(Áõ)
  • pulmonary arteriovenous fistula
    Æóµ¿Á¤¸Æ·ç, ÇãÆÄµ¿Á¤¸Æ»û±æ
  • pulmonary artery
    ÇãÆÄµ¿¸Æ, Æóµ¿¸Æ
  • pulmonary artery wedge pressure
    Æóµ¿¸Æ½û±â¾Ð, ÇãÆÄµ¿¸Æ½û±â¾Ð
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pulmonary perfusion scan
    Æó°ü·ù½ºÄµ, ÇãÆÄ°ü·ù½ºÄµ
  • pulmonary trunk
    Æóµ¿¸Æ, ÇãÆÄµ¿¸Æ
  • pulmonary tuberculosis
    Æó°áÇÙ
  • pulmonary thromboembolism
    ÆóÇ÷Àü»öÀüÁõ, ÇãÆÄÇ÷Àü»öÀüÁõ
  • pulmonary function test
    Æó±â´É°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • rectal valve
    °ðâÀÚÆÇ¸·, Á÷ÀåÆÇ¸·
  • right atrioventricular valve
    ¿À¸¥¹æ½ÇÆÇ¸·, »ïõÆÇ¸·
  • self-sealing valve
    ÀÚµ¿¹æ´©ÆÇ¸·
  • spiral valve
    ³ª¼±ÆÇ¸·
  • tricuspid valve
    (¢¡right atrioventricular valve) ¿À¸¥¹æ½ÇÆÇ¸·, »ï÷ÆÇ¸·
  • valve
    ÆÇ¸·
  • plexogenic pulmonary arteriopathy
    ¾ó±âÇü¼ºÆóµ¿¸Æº´Áõ
  • pulmonary actinomycosis
    ÇãÆÄ¹ÙÄû»ì±ÕÁõ, Æó¹æ¼±±ÕÁõ
  • pulmonary alveolus
    ÇãÆÄ²Ê¸®, ÆóÆ÷
  • pulmonary arch
    ÇãÆÄµ¿¸ÆÈ°
  • pulmonary arteriosclerosis
    Æóµ¿¸Æ°æÈ­Áõ
  • pulmonary artery
    ÇãÆÄµ¿¸Æ, Æóµ¿¸Æ
  • pulmonary blastomycosis
    Æóºí¶ó½ºÅä¹Ì¼¼½ºÁ¾
  • chronic obstructive pulmonary disease
    ¸¸¼ºÆó¼âÆóÁúȯ, ¸¸¼ºÆó¼âÆóº´
  • pulmonary compliance
    ÇãÆÄź¼º, Æóź¼º, ÇãÆÄÀ¯¼øµµ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • ileocecal valve
    ȸ¸ÍÆÇ(üߨî÷û).
  • ileocecal valve
    µ¹¸·Ã¢ÀÚÆÇ¸·
  • ileocecal valve
    ȸ¸ÍÆÇ(ȸ¸ÍÆÇ).
  • inhalation valve
    Èí±â¹ëºê, ÈíÀÔ°ü<ÆÇ> (¡­Î·<÷û>).
  • inspiratory expiratory valve
    ÈíÈ£±â¹ëºê.
  • inspiratory valve
    Èí±â¹ëºê.
  • pop off valve
    ¹è±â¹ëºê, ¾ÈÀü¹ëºê.
  • pop valve =safety v.
    ¾ÈÀüÆÇ(äÌîï÷û).
  • posterior semilunar valve
    ÈĹݿùÆÇ¸·, µÚ¹Ý´ÞÆÇ¸·{ÇØ}
  • posterior semilunar valve
    µÚ¹Ý´ÞÆÇ¸·
  • posterior semilunar valve ³ª valvula semilunaris p.
    µÚ¹Ý´ÞÆÇ¸·, ÈÄ¹Ý ¿ùÆÇ(ý­ÚâêÅ÷û).
  • posterior urethral valve
    Èĺο䵵ÆÇ¸·Áõ
  • predictive valve
    ÃßÁ¤µµ
  • pressure limiting valve
    ¾Ð·ÂÁ¦Çѹëºê.
  • pressure reducing valve
    °¨¾Ð¹ëºê.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • immune disorders
    ¸é¿ªÀå¾Ö(Øóæ¹î¡äô)
  • larynx, congenital disorders of the
    ¼±Ãµ(¼º) ÈĵÎÁúȯ
  • learning disorders
    ÇнÀÀå¾Ö(ùÊã§î¡äô)(º´)
  • mendelian disorders
    ¸àµ¨ À¯Àü¼º Áúȯ(¡­ë¶îîàõ òðü´)
  • monoarticular disorders
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • movement disorders
  • myeloproliferative disorders
    °ñ¼öÁõ½Ä¼ºÁúȯ
  • neuroleptic-induced disorders
  • nutritional disorders
    ¿µ¾çÀÌ»ó<Àå¾Ö>.
  • olfactory disorders
    Èİ¢Àå¾Ö
  • organic voice disorders
    ±âÁú(Àû) À½¼ºÀå¾Ö
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Right inferior pulmonary vein
    ¾Æ·¡¿À¸¥ÇãÆÄÁ¤¸Æ
    [¿¾ ¿ë¾î] ¿ìÇÏÆóÁ¤¸Æ
  • Left inferior pulmonary vein
    ¾Æ·¡¿ÞÇãÆÄÁ¤¸Æ
    [¿¾ ¿ë¾î] ÁÂÇÏÆóÁ¤¸Æ
  • Right pulmonary artery
    ¿À¸¥ÇãÆÄµ¿¸Æ
    [¿¾ ¿ë¾î] ¿ìÆóµ¿¸Æ
  • Common pulmonary vein
    ¿ÂÇãÆÄÁ¤¸Æ
    [¿¾ ¿ë¾î] ÃÑÆóÁ¤¸Æ
  • Left pulmonary artery
    ¿ÞÇãÆÄµ¿¸Æ
    [¿¾ ¿ë¾î] ÁÂÆóµ¿¸Æ
  • Right superior pulmonary vein
    À§¿À¸¥ÇãÆÄÁ¤¸Æ
    [¿¾ ¿ë¾î] ¿ì»óÆóÁ¤¸Æ
  • Left superior pulmonary veins
    À§¿ÞÇãÆÄÁ¤¸Æ
    [¿¾ ¿ë¾î] Á»óÆóÁ¤¸Æ
  • Secondary pulmonary lobule
    ÀÌÂ÷ÇãÆÄ¼Ò¿±
    [¿¾ ¿ë¾î] ÀÌÂ÷Æó¼Ò¿±
  • Primary pulmonary lobule
    ÀÏÂ÷ÇãÆÄ¼Ò¿±
    [¿¾ ¿ë¾î] ÀÏÂ÷Æó¼Ò¿±
  • Pulmonary branches
    ÇãÆÄ°¡Áö
    [¿¾ ¿ë¾î] ÆóÁö
  • Pulmonary groove
    ÇãÆÄ°í¶û
    [¿¾ ¿ë¾î] Æó±¸
  • Pulmonary alveolus
    ÇãÆÄ²Ê¸® [ÆóÆ÷]
    [¿¾ ¿ë¾î] ÆóÆ÷
  • Pulmonary alveoli
    ÇãÆÄ²Ê¸®[ÆóÆ÷]
    [¿¾ ¿ë¾î] ÆóÆ÷
  • Pulmonary alveolar tree
    ÇãÆÄ²Ê¸®¼ÛÀÌ
    [¿¾ ¿ë¾î] ÆóÆ÷
  • Pulmonary artery
    ÇãÆÄµ¿¸Æ
    [¿¾ ¿ë¾î] Æóµ¿¸ÆÆÇ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pulmonary atelectasis
    ¹«±âÆó
  • pulmonary atresia
    Æóµ¿¸ÆÆÇ Æó¼â(Áõ)
  • pulmonary capillary
    Æó¸ð¼¼°ü
  • pulmonary capillary wedge pressure
    Æó¸ð¼¼Ç÷°ü½û±â¾Ð
  • pulmonary circulation
    Æó¼øÈ¯
  • pulmonary circulation time
    Æó¼øÈ¯½Ã°£
  • pulmonary congestion
    Æó¿ïÇ÷
  • pulmonary edema
    ÆóºÎÁ¾
  • pulmonary embolism
    Æó(µ¿¸Æ)»öÀüÁõ
  • pulmonary emphysema
    Æó±âÁ¾
  • pulmonary eosinophilia
    ÆóÈ£»ê±¸Áõ°¡Áõ
  • pulmonary fibrosis
    Æó¼¶À¯Áõ
  • pulmonary function test
    Æó±â´É°Ë»ç
  • pulmonary hemorrhage
    ÆóÃâÇ÷
  • pulmonary hypertrophic osteopathy
    Æó¼ººñ´ë¼º°ñº´Áõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
PPA palpation, percussion, auscultation; pepsin A; phenylpropanolamine; phenylpyruvic acid; Pittsburgh p...
PVG pulmonary valve gradient
ASDC Association of Sleep Disorders Centers; ¹Ì±¹ ¼ö¸é Áúȯ ¼¾ÅÍ Çùȸ
DIMS Disorders of Initiating & Maintaining Sleep; ÀÔ¸éÀå¾Ö ¹× ¼ö¸é À¯Áö Àå¾Ö; ºÒ¸éÁõ
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MV Mitral valve
MVA Mitral valve area
NVE Native valve endocarditis
PVE Prosthetic valve endocarditis
SVD Structural Valve Deterioration
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • valve formation
    ÆÇ¸· Çü¼º, ÆÇ Çü¼º
  • valve leaflet
    ÆÇ¸· Æí
  • valve of foraminis ovalis
    ³­¿ø°ø ÆÇ
  • valve of Kerckring
    µ¹¸²ÁÖ¸§, À±»óÁÖ¸§
  • valve of oval foramen
    Ÿ¿ø ±¸¸Û ÆÇ¸·
  • valve of sinus venosus
    Á¤¸Æµ¿±¼ ÆÇ¸·
  • valve of vein
    Á¤¸ÆÆÇ¸·, ¸ÆÆÇ¸·, Á¤¸ÆÆÇ
  • valve ring
    ÆÇ·û
  • eosinophilic pulmonary syndrome
    È£»ê¼º Æó ÁõÈıº
    ¸¸¼º È£»ê±¸¼º Æó·ÅÀº ÆóÆ÷ ¼¼Ã´À̳ª »ý°Ë»ó È£»ê±¸°¡ Æó Á¶Á÷ÀÇ ¸»Ãʺο¡ Ä§ÂøµÈ ¼Ò°ßÀ» Ư¡À¸·Î ÇÏ´Â ÁõÈıºÀ» ÀǹÌÇÑ´Ù. Ç÷¾× È£»ê±¸ Áõ°¡°¡ ´ëºÎºÐ °üÂûµÈ´Ù. ¸¸¼º È£»ê±¸¼º Æó·ÅÀº ÁÖ·Î ¿©ÀÚ¿¡ ³ªÅ¸³ª¸ç, ¹ß¿­, ¹ßÇÑ, üÁß °¨¼Ò, È£Èí °ï¶õÀÌ Æ¯Â¡ÀÌ´Ù. Ä¡·á´Â °æ±¸
  • hypertrophic pulmonary osteoarthropathy
    ºñÈļº Æó °ñ°üÀýº´Áõ
  • left inferior pulmonary vein
    ¾Æ·¡ ¿Þ ÇãÆÄ Á¤¸Æ
  • main pulmonary artery
    ÁÖ Æó µ¿¸Æ
  • mediastino pulmonary
    Á¾°Ý Æó
  • multiple pulmonary emboli
    ´Ù¹ß¼º Æó »öÀü
  • obstructive pulmonary emphysema
    Æó¼â¼º Æó ±âÁ¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
growth disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. The concept includes both acceleration and retardation of growth.
(12 Dec 1998)
phagocytic dysfunction disorders immunodeficiency Suppression in number or function of phagocytic cells such as in chronic granulomatous disease.
Synonym: phagocytic dysfunction disorders immunodeficiency.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
ciliary motility disorders Disorders characterised by abnormal ciliary movement in the nose, paranasal sinuses, respiratory tract, and spermatozoa. Electron microscopy of the cilia shows that dynein arms are missing. The disorders manifest as kartagener triad (kartagener's syndrome), chronic respiratory disorders, chronic sinusitis, and/or chronic otitis.
(12 Dec 1998)
phobic disorders Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognises the fear as excessive or unreasonable.
(12 Dec 1998)
civil disorders Deliberate and planned acts of unlawful behaviour engaged in by aggrieved segments of the population in seeking social change.
(12 Dec 1998)
phosphorus metabolism disorders Disorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization.
(12 Dec 1998)
photosensitivity disorders Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy.
(12 Dec 1998)
mood disorders Those disorders that have a disturbance in mood as their predominant feature.
(12 Dec 1998)
combat disorders Neurotic reactions to unusual, severe, or overwhelming military stress.
(12 Dec 1998)
communication disorders Disorders characterised by the individual's inability to comprehend or share ideas or feelings because of impairment of language, speech, or hearing.
(12 Dec 1998)
motor skills disorders Marked impairments in the development of motor coordination such that the impairment interferes with activities of daily living.
(12 Dec 1998)
platelet function disorders <haematology> Platelet function can be affected by a number of different disease processes including polycythaemia vera, leukaemia, myelofibrosis, renal failure, multiple myeloma and some medications (for example penicillins, salicylates, phenothiazines).
Disturbed blood clotting can be manifested by: easy bruising, bleeding gums, nosebleeds, abnormal vaginal bleeding, rectal bleeding, skin rash, vomiting blood, coughing up blood or blood in the urine. A measure of bleeding time and coagulation profile will be part of the evaluation.
(31 Dec 1997)
multifactorial or multigenic disorders Genetic disorders resulting from the combined action of alleles of more than one gene (e.g., heart disease, diabetes, and some cancers). Although such disorders are inherited, they depend on the simultaneous presence of several alleles, thus the hereditary patterns are usually more complex than those of single- gene disorders.
Compare single-gene disorders.
(05 Mar 2000)
consciousness disorders Organic mental disorders in which there is marked impairment of awareness.
(12 Dec 1998)
polygenic disorders Genetic disorders resulting from the combined action of alleles of more than one gene (e.g., heart disease, diabetes, and some cancers). Although such disorders are inherited, they depend on the simultaneous presence of several alleles, thus the hereditary patterns are usually more complex than those of single- gene disorders.
Compare single-gene disorders.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á